MedPath

Urinary Retention After Arthroplasty

Not Applicable
Recruiting
Conditions
Arthroplasty Complications
Urinary Retention Postoperative
Registration Number
NCT04707001
Lead Sponsor
Central Finland Hospital District
Brief Summary

Arthroplasty increases the risk of postoperative urinary retention. Treatment of postoperative urinary retention is indwelling or intermittent catheterization. The need for catheterization is most commonly determined with an ultrasound scanner. Catheterization increases the risk of urinary tract infection, which may further lead to haematogenic infection of the artificial joint. There is no evidence of an optimal way to monitor the onset of spontaneous urination.

The aim of the study is to determine whether monitoring the onset of spontaneous urination after fast track knee arthroplasty is safe based on symptoms alone without ultrasound monitoring.

Detailed Description

Adult patients undergoing knee arthroplasty will be recruited to this study. Participants will be randomized to the ultrasound monitoring group or the symptoms alone group. In the symptoms alone group, urination is monitored by asking at regular intervals about the onset of spontaneous urination and the patient is catheterized only on a symptomatic basis or if spontaneous voiding has not started 10 hours after the spinal anesthesia. Symptoms that indicate catheterization are lower abdominal pain or need to void. In the ultrasound group, urinary retention is monitored according to current practice with an ultrasound scanner and the patient is catheterized if residual urine exceeds 800 ml or if the patient is symptomatic.

The primary outcome variable is the change in IPSS score from the baseline to 3 months after the procedure. The baseline score is evaluated preoperatively.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
170
Inclusion Criteria
  • elective total knee arthroplasty
Exclusion Criteria
  • previous surgery for urologic cancer
  • fracture as indication for surgery
  • lack of co-operation
  • untreated urinary retention
  • nephrostoma
  • general anesthesia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
International Prostate Symptom Score (IPSS)3 months after surgery

IPSS questionnaire compared to IPSS before surgery. The minimum score is 0. The maximum score is 35. Higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod
Health-related quality of life (15D) score12 months after surgery

Health-related quality of life(15D) score compared to 15D score before surgery. The minimum score is 0. The maximum score is 1. Higher scores mean a better outcome.

International Prostate Symptom Score (IPSS)12 months after surgery

IPSS questionnaire compared to IPSS before surgery. The minimum score is 0. The maximum score is 35. Higher scores mean a worse outcome.

Incidence of urinary complications12 months after surgery

Incidence of urinary complications

Trial Locations

Locations (1)

Central Finland Hospital Nova

🇫🇮

Jyväskylä, Finland

Central Finland Hospital Nova
🇫🇮Jyväskylä, Finland
Juha Paloneva, MD, PhD
Contact
+358 14 2693119
Juho Sippola, MD
Contact
+358 14 2691908

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.